logo

Last Update

This profile was last updated on 6/10/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong David Weinreich?

David M. Weinreich

Senior Vice President, Late Stage Clinical Development and Medical Affairs

Regeneron Pharmaceuticals , Inc.

HQ Phone:  (914) 847-7000

Direct Phone: (914) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Regeneron Pharmaceuticals , Inc.

777 Old Saw Mill River Road

Tarrytown, New York,10591

United States

Company Description

Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, hig...more

Background Information

Employment History

Senior Vice President, Head Global Development Specialty Medicine

Bayer AG


Executive Medical Director Global Development

Amgen Inc.


Web References(4 Total References)


Faculty | FierceBiotech Drug Development Forum

www.fiercedrugdevforum.com [cached]

David Weinreich, Senior Vice President, Late Stage Clinical Development & Medical Affairs, REGENERON
David Weinreich Senior Vice President, Late Stage Clinical Development & Medical Affairs REGENERON


pharma.bayer.com

Dr. David Weinreich, Head of Therapeutic Area Oncology, Ophthalmology & Neurology, Bayer


www.bloomberg.com

"We want to be a major oncology player," said David Weinreich, who oversees development of Bayer's cancer drugs.
"We are currently exploring radiation as useful in generating that initial immune response," Weinreich said. "We are willing to make those investments and hopefully they will pay off in the next 10 to 15 years," Weinreich said.


pharma.bayer.com

"Bayer's oncology pipeline has grown tremendously over the last years", said David Weinreich, Head of Global Clinical Development Oncology at Bayer HealthCare.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory